Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Bardoxolone

Bardoxolone (RTA 401; CDDO) is an orally active activator of nuclear regulatory factor (NRf-2) and an inhibitor of SARS-CoV-2 3CL protease. Bardoxolone inhibits SARS-CoV-2 3CL protease with an EC50 value of 0.43 μM in vero cells. Bardoxolone also inhibits necroptosis in HT-29 cells with an EC50 value of 1.30 μM by blocking necrosome formation through inhibiting phosphorylation of RIPK1 and RIPK3. Bardoxolone can be used in research on COVID-19, TNF-induced systemic inflammatory response syndrome (SIRS), and cerebral ischemia-reperfusion injury[1][2].

Product Specifications

CAS Number

[218600-44-3]

Product Name Alternative

CDDO; RTA 401

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Keap1-Nrf2; Necroptosis; SARS-CoV; Virus Protease

Type

Reference compound

Related Pathways

Anti-infection; Apoptosis; NF-κB

Applications

Cancer-Kinase/protease

Field of Research

Infection; Inflammation/Immunology; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Bardoxolone.html

Concentration

10mM

Purity

99.50

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CC1(C)CC[C@@]2(C(O)=O)[C@@]([C@](C(C=C3[C@@]4(C)CC[C@]5([H])[C@]3(C)C=C(C#N)C(C5(C)C)=O)=O)([H])[C@@]4(C)CC2)([H])C1

Molecular Formula

C31H41NO4

Molecular Weight

491.66

Precautions

H302, H315, H319, H335

References & Citations

[1]Sun Q, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6 (1) :212.|[2]Wang Y, et al. Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors. Eur J Med Chem. 2021 Feb 15;212:113030.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-14909/Bardoxolone-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-14909/Bardoxolone-SDS-MedChemExpress.pdf

Scientific Category

Reference compound1

Clinical Information

Phase 3

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

C1QC Human Pre-designed siRNA Set A
HY-RS01721 1 Set

C1QC Human Pre-designed siRNA Set A

Ask
View Details
N, N'- (1S,2S) -1,2-Cyclohexanediylbis[N'-[3,5-bis (trifluoromethyl) phenyl]thiourea]
PC110771-01 100 mg

N, N'- (1S,2S) -1,2-Cyclohexanediylbis[N'-[3,5-bis (trifluoromethyl) phenyl]thiourea]

Ask
View Details
N, N'- (1S,2S) -1,2-Cyclohexanediylbis[N'-[3,5-bis (trifluoromethyl) phenyl]thiourea]
PC110771-02 250 mg

N, N'- (1S,2S) -1,2-Cyclohexanediylbis[N'-[3,5-bis (trifluoromethyl) phenyl]thiourea]

Ask
View Details
N, N'- (1S,2S) -1,2-Cyclohexanediylbis[N'-[3,5-bis (trifluoromethyl) phenyl]thiourea]
PC110771-03 1 g

N, N'- (1S,2S) -1,2-Cyclohexanediylbis[N'-[3,5-bis (trifluoromethyl) phenyl]thiourea]

Ask
View Details
Spry2-set siRNA/shRNA/RNAi Lentivector (Rat)
45399096 4 x 500 ng

Spry2-set siRNA/shRNA/RNAi Lentivector (Rat)

Ask
View Details
Imidapril Impurity 3
RM-I131803-01 10 mg

Imidapril Impurity 3

Ask
View Details